| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.01 | 0.8 |